β-Adrenergic receptor signaling in the heart: Role of CaMKII

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 2, 2010, Pages 322-330

  Grimm, Michael ^a   Brown, Joan Heller ^a  

^a San Diego   (United States)

Author keywords

Apoptosis; Arrhythmia; Beta adrenergic receptor signaling; CaMKII; Excitation contraction coupling; Heart failure; Hypertrophy

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; CARDIAC MYOSIN; HISTONE DEACETYLASE; NIFEDIPINE; PHOSPHOLAMBAN; RYANODINE RECEPTOR;

DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GENE DELETION; HEART FAILURE; HEART FUNCTION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; ENZYME ACTIVATION; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION;

EID: 74149088545     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.10.016     Document Type: Review

References (127)

1. Communal C., Singh K., Pimentel D.R., and Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98 13 (1998 Sep 29) 1329-1334
2. Zhu W.Z., Wang S.Q., Chakir K., Yang D., Zhang T., Brown J.H., et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J. Clin. Invest. 111 5 (2003 Mar) 617-625
3. Zhu W.Z., Zheng M., Koch W.J., Lefkowitz R.J., Kobilka B.K., and Xiao R.P. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 98 4 (2001 Feb 13) 1607-1612
4. Okumura S., Takagi G., Kawabe J., Yang G., Lee M.C., Hong C., et al. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc. Natl. Acad. Sci. U. S. A. 100 17 (2003 Aug 19) 9986-9990
5. Tang T., Gao M.H., Lai N.C., Firth A.L., Takahashi T., Guo T., et al. Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation 117 1 (2008 Jan 1) 61-69
6. White D.C., Hata J.A., Shah A.S., Glower D.D., Lefkowitz R.J., and Koch W.J. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 97 10 (2000 May 9) 5428-5433
7. Shah A.S., White D.C., Emani S., Kypson A.P., Lilly R.E., Wilson K., et al. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation 103 9 (2001 Mar 6) 1311-1316
8. Baltas L.G., Karczewski P., Bartel S., and Krause E.G. The endogenous cardiac sarcoplasmic reticulum Ca2+/calmodulin dependent kinase is activated in response to beta-adrenergic stimulation and becomes Ca2+-independent in intact beating hearts. FEBS Lett. 409 2 (1997 Jun 9) 131-136
9. Kuschel M., Karczewski P., Hempel P., Schlegel W.P., Krause E.G., and Bartel S. Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation. Am. J. Physiol. 276 5 Pt 2 (1999 May) H1625-H1633
10. Ferrero P., Said M., Sanchez G., Vittone L., Valverde C., Donoso P., et al. Ca2+- kinase II increases ryanodine binding and Ca2+-induced sarcoplasmic reticulum Ca2 release kinetics during beta-adrenergic stimulation. J. Mol. Cell. Cardiol. 43 3 (2007 Sep) 281-291
11. Said M., Mundina-Weilenmann C., Vittone L., and Mattiazzi A. The relative relevance of phosphorylation of the Thr(17) residue of phospholamban is different at different levels of beta-adrenergic stimulation. Pflugers Arch. 444 6 (2002 Sep) 801-809
12. Curran J., Hinton M.J., Rios E., Bers D.M., and Shannon T.R. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ. Res. 100 3 (2007 Feb 16) 391-398
13. Wang W., Zhu W., Wang S., Yang D., Crow M.T., Xiao R.P., et al. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. Circ. Res. 95 8 (2004 Oct 15) 798-806
14. Sucharov C.C., Mariner P.D., Nunley K.R., Long C., Leinwand L., and Bristow M.R. A beta1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ. Physiol. 291 3 (2006 Sep) H1299-H1308
15. 2+ sparks and Ca2+ in cardiac myocytes. Circ. Res. 100 3 (2007 Feb 16) 399-407
16. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat. Med. 11 4 (2005 Apr) 409-417
17. Zhu W., Woo A.Y., Yang D., Cheng H., Crow M.T., and Xiao R.P. Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J. Biol. Chem. 282 14 (2007 Apr) 10833-10839
18. 2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J. Physiol. 583 Pt 2 (2007 Sep 1) 685-694
19. Hudmon A., and Schulman H. Structure-function of the multifunctional Ca2+-/dependent protein kinase II. Biochem. J. 364 Pt 3 (2002 Jun 15) 593-611
20. Simmerman H.K., Collins J.H., Theibert J.L., Wegener A.D., and Jones L.R. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261 28 (1986 Oct 5) 13333-13341
21. Wegener A.D., Simmerman H.K., Lindemann J.P., and Jones L.R. Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to beta-adrenergic stimulation. J. Biol. Chem. 264 19 (1989 Jul 5) 11468-11474
22. Huke S., and Bers D.M. Ryanodine receptor phosphorylation at Serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 376 1 (2008 Nov 7) 80-85
23. 2+ oscillations. Science 279 5348 (1998 Jan 9) 227-230
24. Bartel S., Vetter D., Schlegel W.P., Wallukat G., Krause E.G., and Karczewski P. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 32 12 (2000 Dec) 2173-2185
25. Song Q., Saucerman J.J., Bossuyt J., and Bers D.M. Differential integration of Ca2+-calmodulin signal in intact ventricular myocytes at low and high affinity Ca2+-calmodulin targets. J. Biol. Chem. 283 46 (2008 Nov 14) 31531-31540
26. Saucerman J.J., and Bers D.M. Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca2+- cardiac myocytes. Biophys. J. 95 10 (2008 Nov 15) 4597-4612
27. 2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116 3 (2006 Mar) 675-682
28. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133 3 (2008 May 2) 462-474
29. Zhang G.X., Kimura S., Nishiyama A., Shokoji T., Rahman M., Yao L., et al. Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc. Res. 65 1 (2005 Jan 1) 230-238
30. Singal P.K., Kapur N., Dhillon K.S., Beamish R.E., and Dhalla N.S. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60 11 (1982 Nov) 1390-1397
31. Remondino A., Kwon S.H., Communal C., Pimentel D.R., Sawyer D.B., Singh K., et al. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ. Res. 92 2 (2003 Feb 7) 136-138
32. Huke S., and Bers D.M. Temporal dissociation of frequency-dependent acceleration of relaxation and protein phosphorylation by CaMKII. J. Mol. Cell. Cardiol. 42 3 (2007 Mar) 590-599
33. Bradshaw J.M., Kubota Y., Meyer T., and Schulman H. An ultrasensitive Ca2+/calmodulin dependent protein kinase II-protein phosphatase 1 switch facilitates specificity in postsynaptic calcium signaling. Proc. Natl. Acad. Sci. U. S. A. 100 18 (2003 Sep 2) 10512-10517
34. El-Armouche A., Wittkopper K., Degenhardt F., Weinberger F., Didie M., Melnychenko I., et al. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc. Res. 80 3 (2008 Dec 1) 396-406
35. Mauban J.R., O'Donnell M., Warrier S., Manni S., and Bond M. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda). 24 (2009 Apr) 78-87
36. Carnegie G.K., Means C.K., and Scott J.D. A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 61 4 (2009 Apr) 394-406
37. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 6710 (1998 Dec 3) 474-477
38. 2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II. J. Biol. Chem. 284 3 (2009 Jan 16) 1514-1522
39. 2+ mobilization in cardiac myocytes. J. Biol. Chem. 282 8 (2007 Feb 23) 5488-5495
40. Metrich M., Lucas A., Gastineau M., Samuel J.L., Heymes C., Morel E., et al. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ. Res. 102 8 (2008 Apr 25) 959-965
41. Cazorla O., Lucas A., Poirier F., Lacampagne A., and Lezoualc'h F. The cAMP binding protein Epac regulates cardiac myofilament function. Proc. Natl. Acad. Sci. U. S. A. 106 33 (2009 Aug 18) 14144-14149
42. Schmidt M., Evellin S., Weernink P.A., von Dorp F., Rehmann H., Lomasney J.W., et al. A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat. Cell. Biol. 3 11 (2001 Nov) 1020-1024
43. 2+- leak in heart failure. Circ. Res. 97 12 (2005 Dec 9) 1314-1322
44. Hothi S.S., Gurung I.S., Heathcote J.C., Zhang Y., Booth S.W., Skepper J.N., et al. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflugers. Arch. 457 2 (2008 Nov) 253-270
45. Wu Y., Temple J., Zhang R., Dzhura I., Zhang W., Trimble R., et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 106 10 (2002 Sep 3) 1288-1293
46. Lader A.S., Xiao Y.F., Ishikawa Y., Cui Y., Vatner D.E., Vatner S.F., et al. Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proc. Natl. Acad. Sci. U. S. A. 95 16 (1998 Aug 4) 9669-9674
47. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 4 (2000 May 12) 365-376
48. Wehrens X.H., Lehnart S.E., Reiken S.R., and Marks A.R. Ca2+/calmodulin dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 94 6 (2004 Apr 2) e61-e70
49. Xiao B., Jiang M.T., Zhao M., Yang D., Sutherland C., Lai F.A., et al. Characterization of a novel PKA phosphorylation site, serine-2030, reveals no PKA hyperphosphorylation of the cardiac ryanodine receptor in canine heart failure. Circ. Res. 96 8 (2005 Apr 29) 847-855
50. Wehrens X.H., Lehnart S.E., Reiken S., Vest J.A., Wronska A., and Marks A.R. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc. Natl. Acad. Sci. U. S. A. 103 3 (2006 Jan 17) 511-518
51. Rodriguez P., Bhogal M.S., and Colyer J. Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. J. Biol. Chem. 278 40 (2003 Oct 3) 38593-38600
52. Witcher D.R., Kovacs R.J., Schulman H., Cefali D.C., and Jones L.R. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 266 17 (1991 Jun 15) 11144-11152
53. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross Jr. J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92 8 (2003 May 2) 912-919
54. Zalk R., Lehnart S.E., and Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Annu. Rev. Biochem. 76 (2007) 367-385
55. Valverde C.A., Mundina-Weilenmann C., Said M., Ferrero P., Vittone L., Salas M., et al. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation. J. Physiol. 562 Pt 3 (2005 Feb 1) 801-813
56. Talosi L., Edes I., and Kranias E.G. Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts. Am. J. Physiol. 264 3 Pt 2 (1993 Mar) H791-H797
57. Yoo B., Lemaire A., Mangmool S., Wolf M.J., Curcio A., Mao L., et al. Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 297 4 (2009 Oct) H1377-H1386
58. Hagemann D., Kuschel M., Kuramochi T., Zhu W., Cheng H., and Xiao R.P. Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J. Biol. Chem. 275 29 (2000 Jul 21) 22532-22536
59. Mundina-Weilenmann C., Vittone L., Ortale M., de Cingolani G.C., and Mattiazzi A. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J. Biol. Chem. 271 52 (1996 Dec 27) 33561-33567
60. Ji Y., Li B., Reed T.D., Lorenz J.N., Kaetzel M.A., and Dedman J.R. Targeted inhibition of Ca2+/calmodulin dependent protein kinase II in cardiac longitudinal sarcoplasmic reticulum results in decreased phospholamban phosphorylation at threonine 17. J. Biol. Chem. 278 27 (2003 Jul 4) 25063-250671
61. 2+- homeostasis and cardiac contractility. Am. J. Physiol. Heart Circ. Physiol. 290 2 (2006 Feb) H599-H606
62. Vittone L., Mundina-Weilenmann C., and Mattiazzi A. Phospholamban phosphorylation by CaMKII under pathophysiological conditions. Front. Biosci. 13 (2008) 5988-6005
63. 2+ molecules. Nature 341 6237 (1989 Sep 7) 65-68
64. Yuan W., and Bers D.M. Ca-dependent facilitation of cardiac Ca current is due to Ca-calmodulin-dependent protein kinase. Am. J. Physiol. 267 3 Pt 2 (1994 Sep) H982-H993
65. 2+ current in rabbit ventricular myocytes. Circ. Res. 75 5 (1994 Nov) 854-861
66. Xiao R.P., Cheng H., Lederer W.J., Suzuki T., and Lakatta E.G. Dual regulation of Ca2+/calmodulin dependent kinase II activity by membrane voltage and by calcium influx. Proc. Natl. Acad. Sci. U. S. A. 91 20 (1994 Sep 27) 9659-9663
67. Dzhura I., Wu Y., Colbran R.J., Balser J.R., and Anderson M.E. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat. Cell Biol. 2 3 (2000 Mar) 173-177
68. Jahn H., Nastainczyk W., Rohrkasten A., Schneider T., and Hofmann F. Site-specific phosphorylation of the purified receptor for calcium-channel blockers by cAMP-and cGMP-dependent protein kinases, protein kinase C, calmodulin-dependent protein kinase II and casein kinase II. Eur. J. Biochem. 178 2 (1988 Dec 15) 535-542
69. 2+ signals for facilitation. J. Cell. Biol. 171 3 (2005 Nov 7) 537-547
70. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19 1 (1997 Jul) 185-196
71. 2+ channels in cardiac myocytes requires the distal carboxyl terminus of alpha1C but not serine 1928. Circ. Res. 98 2 (2006 Feb 3) e11-e18
72. Lemke T., Welling A., Christel C.J., Blaich A., Bernhard D., Lenhardt P., et al. Unchanged beta-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice. J. Biol. Chem. 283 50 (2008 Dec 12) 34738-34744
73. Grueter C.E., Colbran R.J., and Anderson M.E. CaMKII, an emerging molecular driver for calcium homeostasis, arrhythmias, and cardiac dysfunction. J. Mol. Med. (2006 Nov 21)
74. Grueter C.E., Abiria S.A., Wu Y., Anderson M.E., and Colbran R.J. Differential regulated interactions of calcium/calmodulin-dependent protein kinase II with isoforms of voltage-gated calcium channel beta subunits. Biochemistry 47 6 (2008 Feb 12) 1760-1767
75. Nagayama T., Takimoto E., Sadayappan S., Mudd J.O., Seidman J.G., Robbins J., et al. Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation. Circulation 116 21 (2007 Nov 20) 2399-2408
76. Sadayappan S., Osinska H., Klevitsky R., Lorenz J.N., Sargent M., Molkentin J.D., et al. Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc. Natl. Acad. Sci. U. S. A. 103 45 (2006 Nov 7) 16918-16923
77. Sadayappan S., Gulick J., Osinska H., Martin L.A., Hahn H.S., Dorn II G.W., et al. Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ. Res. 97 11 (2005 Nov 25) 1156-1163
78. Hartzell H.C., and Glass D.B. Phosphorylation of purified cardiac muscle C-protein by purified cAMP-dependent and endogenous Ca2+-calmodulin-dependent protein kinases. J. Biol. Chem. 259 24 (1984 Dec 25) 15587-15596
79. Gautel M., Zuffardi O., Freiburg A., and Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?. Embo J. 14 9 (1995 May 1) 1952-1960
80. Mohamed A.S., Dignam J.D., and Schlender K.K. Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites. Arch. Biochem. Biophys. 358 2 (1998 Oct 15) 313-319
81. Hartzell H.C., and Titus L. Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. J. Biol. Chem. 257 4 (1982 Feb 25) 2111-2120
82. Neumann J., Gupta R.C., Jones L.R., Bodor G.S., Bartel S., Krause E.G., et al. Interaction of beta-adrenoceptor and adenosine receptor agonists on phosphorylation. Identification of target proteins in mammalian ventricles. J. Mol. Cell. Cardiol. 27 8 (1995 Aug) 1655-1667
83. El-Armouche A., Pohlmann L., Schlossarek S., Starbatty J., Yeh Y.H., Nattel S., et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J. Mol. Cell. Cardiol. 43 2 (2007 Aug) 223-229
84. 2+ handling in human chronic atrial fibrillation. Circulation 114 7 (2006 Aug 15) 670-680
85. Bossuyt J., Helmstadter K., Wu X., Clements-Jewery H., Haworth R.S., Avkiran M., et al. Ca2+-/dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ. Res. 102 6 (2008 Mar 28) 695-702
86. Zhang T., Kohlhaas M., Backs J., Mishra S., Phillips W., Dybkova N., et al. CaMKII{delta} isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J. Biol. Chem. 282 48 (2007 Nov 30) 35078-35087
87. Backs J., Backs T., Bezprozvannaya S., McKinsey T.A., and Olson E.N. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol. Cell. Biol. 28 10 (2008 May) 3437-3445
88. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N., and CaM kinase I.I. selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116 7 (2006 Jul) 1853-1864
89. Ling H., Zhang T., Pereira L., Means C.K., Cheng H., Gu Y., et al. Requirement for Ca2+/calmodulin dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. (2009) doi:10.1172/JCI38022
90. Kitagawa Y., Tamura Y., Shimizu J., Nakajima-Takenaka C., Taniguchi S., Uesato S., et al. Effects of a novel histone deacetylase inhibitor, N-(2-aminophenyl) benzamide, on a reversible hypertrophy induced by isoproterenol in in situ rat hearts. J. Pharmacol. Sci. 104 2 (2007 Jun) 167-175
91. DiFrancesco D., and Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351 6322 (1991 May 9) 145-147
92. Joung B., Tang L., Maruyama M., Han S., Chen Z., Stucky M., et al. Intracellular calcium dynamics and acceleration of sinus rhythm by beta-adrenergic stimulation. Circulation 119 6 (2009 Feb 17) 788-796
93. Herrmann S., Stieber J., Stockl G., Hofmann F., and Ludwig A. HCN4 provides a 'depolarization reserve' and is not required for heart rate acceleration in mice. Embo J. 26 21 (2007 Oct 31) 4423-4432
94. Vinogradova T.M., Zhou Y.Y., Bogdanov K.Y., Yang D., Kuschel M., Cheng H., et al. Sinoatrial node pacemaker activity requires Ca(2)/calmodulin-dependent protein kinase II activation. Circ. Res. 87 9 (2000 Oct 27) 760-767
95. Wu Y., Gao Z., Chen B., Koval O.M., Singh M.V., Guan X., et al. Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc. Natl. Acad. Sci. U. S. A. (2009 Mar 10)
96. Rigg L., Heath B.M., Cui Y., and Terrar D.A. Localisation and functional significance of ryanodine receptors during beta-adrenoceptor stimulation in the guinea-pig sino-atrial node. Cardiovasc. Res. 48 2 (2000 Nov) 254-264
97. Vinogradova T.M., Bogdanov K.Y., and Lakatta E.G. beta-Adrenergic stimulation modulates ryanodine receptor Ca(2) release during diastolic depolarization to accelerate pacemaker activity in rabbit sinoatrial nodal cells. Circ. Res. 90 1 (2002 Jan 11) 73-79
98. 2+ release is not a dominating factor in sinoatrial node pacemaker activity. Circ. Res. 92 3 (2003 Feb 21) e41-e44
99. Lakatta E.G., and DiFrancesco D. What keeps us ticking: a funny current, a calcium clock, or both?. J. Mol. Cell. Cardiol. 47 2 (2009 Aug) 157-170
100. Vinogradova T.M., and Lakatta E.G. Regulation of basal and reserve cardiac pacemaker function by interactions of cAMP-mediated PKA-dependent Ca(2) cycling with surface membrane channels. J. Mol. Cell. Cardiol. (2009 Jun 30)
101. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy J.J., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ. Res. 75 3 (1994 Sep) 401-409
102. Chu G., Lester J.W., Young K.B., Luo W., Zhai J., and Kranias E.G. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J. Biol. Chem. 275 49 (2000 Dec 8) 38938-38943
103. Kiss E., Edes I., Sato Y., Luo W., Liggett S.B., and Kranias E.G. beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts. Am. J. Physiol. 272 2 Pt 2 (1997 Feb) H785-H790
104. Wehrens X.H., Lehnart S.E., Huang F., Vest J.A., Reiken S.R., Mohler P.J., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113 7 (2003 Jun 27) 829-840
105. Gomez A.M., Valdivia H.H., Cheng H., Lederer M.R., Santana L.F., Cannell M.B., et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276 5313 (1997 May 2) 800-806
106. Stange M., Xu L., Balshaw D., Yamaguchi N., and Meissner G. Characterization of recombinant skeletal muscle (Ser-2843) and cardiac muscle (Ser-2809) ryanodine receptor phosphorylation mutants. J. Biol. Chem. 278 51 (2003 Dec 19) 51693-51702
107. Xiao B., Sutherland C., Walsh M.P., and Chen S.R. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ. Res. 94 4 (2004 Mar 5) 487-495
108. Benkusky N.A., Weber C.S., Scherman J.A., Farrell E.F., Hacker T.A., John M.C., et al. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ. Res. 101 8 (2007 Oct 12) 819-829
109. MacDonnell S.M., Garcia-Rivas G., Scherman J.A., Kubo H., Chen X., Valdivia H., et al. Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808. Circ. Res. 102 8 (2008 Apr 25) e65-e72
110. Currie S., Loughrey C.M., Craig M.A., and Smith G.L. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart. Biochem. J. 377 Pt 2 (2004 Jan 15) 357-366
111. Hain J., Onoue H., Mayrleitner M., Fleischer S., and Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J. Biol. Chem. 270 5 (1995 Feb 3) 2074-2081
112. 2+ release. Circ. Res. 92 8 (2003 May 2) 904-911
113. Yurukova S., Kilic A., Volker K., Leineweber K., Dybkova N., Maier L.S., et al. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice. Cardiovasc. Res. 73 4 (2007 Mar 1) 678-688
114. Wu Y., Shintani A., Grueter C., Zhang R., Hou Y., Yang J., et al. Suppression of dynamic Ca(2) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition. J. Mol. Cell. Cardiol. 40 2 (2006 Feb) 213-223
115. Guo T., Zhang T., Mestril R., and Bers D.M. Ca2+/calmodulin dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ. Res. 99 4 (2006 Aug 18) 398-406
116. Hoch B., Meyer R., Hetzer R., Krause E.G., and Karczewski P. Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84 6 (1999 Apr 2) 713-721
117. Kirchhefer U., Schmitz W., Scholz H., and Neumann J. Activity of cAMP-dependent protein kinase and Ca2+-/dependent protein kinase in failing and nonfailing human hearts. Cardiovasc. Res. 42 1 (1999 Apr) 254-261
118. Nakayama H., Chen X., Baines C.P., Klevitsky R., Zhang X., Zhang H., et al. Ca2+-and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 117 9 (2007 Sep) 2431-2444
119. Vila-Petroff M., Salas M.A., Said M., Valverde C.A., Sapia L., Portiansky E., et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc. Res. 73 4 (2007 Mar 1) 689-698
120. Yang Y., Zhu W.Z., Joiner M.L., Zhang R., Oddis C.V., Hou Y., et al. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. Am. J. Physiol. Heart. Circ. Physiol. 291 6 (2006 Dec) H3065-H3075
121. Khoo M.S., Li J., Singh M.V., Yang Y., Kannankeril P., Wu Y., et al. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Circulation 114 13 (2006 Sep 26) 1352-1359
122. Couchonnal L.F., and Anderson M.E. The role of calmodulin kinase II in myocardial physiology and disease. Physiology (Bethesda). 23 (2008 Jun) 151-159
123. Kohlhaas M., Zhang T., Seidler T., Zibrova D., Dybkova N., Steen A., et al. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ. Res. 98 2 (2006 Feb 3) 235-244
124. Olofsson M.H., Havelka A.M., Brnjic S., Shoshan M.C., and Linder S. Charting calcium-regulated apoptosis pathways using chemical biology: role of calmodulin kinase II. BMC. Chem. Biol. 8 (2008) 2
125. Zhang G.X., Ohmori K., Nagai Y., Fujisawa Y., Nishiyama A., Abe Y., et al. Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice. J. Mol. Cell. Cardiol. 42 4 (2007 Apr) 804-811
126. Xie L.H., Chen F., Karagueuzian H.S., and Weiss J.N. Oxidative stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ. Res. 104 1 (2009 Jan 2) 79-86
127. Sag C.M., Wadsack D.P., Khabbazzadeh S., Abesser M., Grefe C., Neumann K., et al. CaMKII contributes to cardiac arrhythmogenesis in heart failure. Circulation:. Heart. Failure. (2009 July 31) doi: 10.1161/CIRCHEARTFAILURE.109.865279